Antiviral humoral immunity against SARS-CoV-2 omicron JN.1 subvariants induced by JN.1 recombinant protein vaccine

Saved in:
Bibliographic Details
Published inVaccine Vol. 54; p. 127129
Main Authors Uriu, Keiya, Kaku, Yu, Kihara, Minoru, Sato, Kei
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 30.04.2025
Elsevier Limited
Subjects
Allergy and Immunology
Antibodies
COVID-19 vaccines
HIV
Human immunodeficiency virus
Human subjects
Humoral immunity
Immunity (Disease)
Infectious diseases
Lymphocytes
mRNA vaccines
Plasmids
Proteins
R&D
Research & development
Severe acute respiratory syndrome coronavirus 2
Vaccines
Japan
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Commentary-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:0264-410X
1873-2518
1873-2518
DOI:10.1016/j.vaccine.2025.127129